Cite
HARVARD Citation
Tibaldi, C. et al. (2018). Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study. British journal of cancer. 119 (11), pp. 1326-1331. [Online].